Study of Efficacy and Safety of Twice Daily Oral Iptacopan (LNP023) in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
Clinical trial NCT04820530 · COMPLETED
Trial details
- NCT number
- NCT04820530
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2022-11-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.